P/B
95,6
Establishment Labs
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
$2.1B
Market Cap • 9/18/2026
2004
(22 years)
Founded
2018
(8 years ago)
IPO
NASDAQ
Listing Exchange
United States
Country
Valuation
P/S
8,4
P/EBITDA
—
P/OCF
—
P/FCF
—
P/E
—
BVPS
0,7
EPS
—
Market Cap
Market Cap
2,1B
EV
2,3B
EV/Revenue
9,2
EV/EBITDA
-279,3
EV/EBIT
-120,4
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
-1,1%
Total Yield
-1,1%
Payout
0%
Retained Earnings
-520,9M
Profitability
Gross Margin
70,5%
EBITDA Margin
—
EBIT Margin
—
Net Margin
—
D&A/EBITDA
0%
R&D/Revenue
8,3%
Capex/Revenue
3,7%
Capex/D&A
86%
Capex/OCF
-28,4%
SBC/OCF
—
% PPE
22%
% Goodwill
0,3%
ROE
—
ROIC
—
Growth
CAGR Revenue 5Y
17%
CAGR Op. Income 5Y
1,6%
CAGR Net Income 5Y
11,9%
CAGR EPS 5Y
7,3%
CAGR OCF 5Y
35,9%
Leverage
N.D./EBITDA
—
Debt/Equity
0%
Current Ratio
3,8
Quick Ratio
2,3
Interest Coverage
—
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!